Back to top

HCA Healthcare price target lowered to $579 from $635 at UBS

UBS analyst AJ Rice lowered the firm’s price target on HCA Healthcare (HCA) to $579 from $635 and keeps a Buy rating on the shares. Published first...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

HCA Healthcare, Inc. (HCA)